VRX Share Price

Open 16.42 Change Price %
High 16.53 1 Day -0.40 -2.41
Low 16.10 1 Week 0.14 0.87
Close 16.18 1 Month 2.19 15.65
Volume 10614527 1 Year -68.53 -80.90
52 Week High 76.95
52 Week Low 13.00
VRX Important Levels
Resistance 2 16.58
Resistance 1 16.41
Pivot 16.27
Support 1 15.95
Support 2 15.78
NYSE USA Most Active Stocks
EMC 29.05 0.97%
EMC 29.05 0.97%
EMC 29.05 0.97%
BAC 24.23 -1.42%
BAC 24.23 -1.42%
BAC 24.23 -1.42%
SE 40.68 -0.78%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
More..
NYSE USA Top Gainers Stocks
POM 26.93 26.79%
POM 26.93 26.79%
BBW 10.10 21.69%
FIX 38.65 17.66%
FIX 38.65 17.66%
FNP 35.24 12.02%
FNP 35.24 12.02%
DMD 6.35 9.48%
DMD 6.35 9.48%
FL 75.01 9.38%
More..
NYSE USA Top Losers Stocks
ENL 15.81 -66.25%
ENL 15.81 -66.25%
ENL 15.81 -66.25%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
More..

Valeant Pharmaceuticals International, Inc. (NYSE: VRX)

VRX Technical Analysis 2.5
As on 24th Feb 2017 VRX Share Price closed @ 16.18 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 22.88 & Strong Buy for SHORT-TERM with Stoploss of 14.89 we also expect STOCK to react on Following IMPORTANT LEVELS.
VRX Target for February
1st Target up-side 16.17
2nd Target up-side 17.85
3rd Target up-side 19.53
1st Target down-side 11.39
2nd Target down-side 9.71
3rd Target down-side 8.03
VRX Other Details
Segment EQ
Market Capital 16095334400.00
Sector Healthcare
Industry Drug Delivery
Offical website http://www.valeant.com
VRX Address
VRX
2150 St. Elz
Laval, QC H7L 4A8
Canada
Phone: 514-744-6792
Fax: 514-744-6272
Interactive Technical Analysis Chart Valeant Pharmaceuticals International, Inc. ( VRX NYSE USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Valeant Pharmaceuticals International, Inc.
VRX Business Profile
Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter (OTC) products, and medical devices in the areas of eye health, dermatology, and neurology therapeutic classes worldwide. Its pharmaceutical products include Solodyn, an oral antibiotic that treats red and pus-filled pimples, as well as Ziana, Acanya, and Atralin; Wellbutrin XL, a formulation used for the treatment of major depressive disorder in adults; Xenazine for the treatment of chorea; Zovirax Cream for herpes labialis; Zovirax ointment for initial genital herpes; The Lotemax gel for post-operative inflammation and pain; Arestin, a subgingival sustained-release antibiotic; and Prolensa, a non-steroidal anti-inflammatory ophthalmic solution. The company also provides OTC products, such as PreserVision, an antioxidant eye vitamin and mineral supplement; ReNu Multiplus, a sterile that is used to lubricate and rewet soft contact lenses; Ocuvite, a lutein eye vitamin and mineral supplement; Artelac, an eye drops to treat dry eyes; and CeraVe products for skin. In addition, it offers device products, including SofLens daily disposable contact lenses; Restylane, an injectable implant dermal fillers; PureVision, a contact lens; Dysport, an injection neurotoxin; ophthalmic surgical products, such as Akreos and Crystalens; surgical equipment comprising the VICTUS femtosecond laser and the Stellaris PC, a vitreoretinal and cataract surgery system; and medical device systems for aesthetic applications. Further, it provides generic products comprising Retin-A Micro, a tretinoin gel; tobramycin and dexamethasone ophthalmic suspensions for steroid responsive inflammatory ocular conditions; and latanoprost to treat glaucoma. The company was formerly known as Biovail Corporation and changed its name to Valeant Pharmaceuticals International, Inc. in September 2010. Valeant Pharmaceuticals International, Inc. was founded in 1983 and is headquartered in Laval, Canada.